Arcadia Biosciences's Total Assets for the quarter that ended in Dec. 2023 was $19.71 Mil.
During the past 12 months, Arcadia Biosciences's average Total Assets Growth Rate was -2.60% per year.
During the past 3 years, the average Total Assets Growth Rate was -28.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 20.60% per year.
During the past 10 years, the average Total Assets Growth Rate was 2.60% per year.
During the past 12 years, Arcadia Biosciences's highest 3-Year average Total Assets Growth Rate was 90.60%. The lowest was -54.90%. And the median was 4.60%.
The historical data trend for Arcadia Biosciences's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Arcadia Biosciences's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcadia Biosciences (NAS:RKDA) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Arcadia Biosciences's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Arcadia Biosciences Total Assets Related Terms
Thank you for viewing the detailed overview of Arcadia Biosciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Arcadia Biosciences (Arcadia Biosciences) Business Description
Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RKDA has been successfully added to your 